Citadel Advisors’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-367,974
| Closed | -$115K | – | 6657 |
|
|
2025
Q1 | $115K | Buy |
367,974
+360,517
| +4,835% | +$112K | ﹤0.01% | 5100 |
|
|
2024
Q4 | $6.96K | Buy |
+7,457
| New | +$6.96K | ﹤0.01% | 5747 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 6442 |
|
|
2024
Q2 | – | Sell |
-147,339
| Closed | -$449K | – | 6562 |
|
|
2024
Q1 | $449K | Buy |
147,339
+136,137
| +1,215% | +$415K | ﹤0.01% | 4021 |
|
|
2023
Q4 | $36.1K | Buy |
+11,202
| New | +$36.1K | ﹤0.01% | 5228 |
|
|
2023
Q3 | – | Sell |
-30,812
| Closed | -$101K | – | 6321 |
|
|
2023
Q2 | $101K | Sell |
30,812
-27,025
| -47% | -$88.6K | ﹤0.01% | 4748 |
|
|
2023
Q1 | $149K | Buy |
57,837
+19,809
| +52% | +$51.1K | ﹤0.01% | 4746 |
|
|
2022
Q4 | $70.7K | Buy |
+38,028
| New | +$70.7K | ﹤0.01% | 5150 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6466 |
|
|
2022
Q2 | – | Sell |
-38,265
| Closed | -$120K | – | 6673 |
|
|
2022
Q1 | $120K | Sell |
38,265
-40,160
| -51% | -$126K | ﹤0.01% | 5549 |
|
|
2021
Q4 | $252K | Sell |
78,425
-18,599
| -19% | -$59.8K | ﹤0.01% | 5275 |
|
|
2021
Q3 | $326K | Buy |
97,024
+60,911
| +169% | +$205K | ﹤0.01% | 4955 |
|
|
2021
Q2 | $141K | Sell |
36,113
-45,655
| -56% | -$178K | ﹤0.01% | 5779 |
|
|
2021
Q1 | $329K | Buy |
81,768
+3,963
| +5% | +$15.9K | ﹤0.01% | 4943 |
|
|
2020
Q4 | $180K | Sell |
77,805
-23,005
| -23% | -$53.2K | ﹤0.01% | 4540 |
|
|
2020
Q3 | $579K | Buy |
100,810
+78,730
| +357% | +$452K | ﹤0.01% | 3368 |
|
|
2020
Q2 | $163K | Buy |
+22,080
| New | +$163K | ﹤0.01% | 4133 |
|
|
2020
Q1 | – | Sell |
-38,088
| Closed | -$158K | – | 5166 |
|
|
2019
Q4 | $158K | Buy |
+38,088
| New | +$158K | ﹤0.01% | 4192 |
|
|
2018
Q4 | – | Sell |
-14,537
| Closed | -$82K | – | 4830 |
|
|
2018
Q3 | $82K | Buy |
+14,537
| New | +$82K | ﹤0.01% | 3940 |
|
|
2017
Q3 | – | Sell |
-19,493
| Closed | -$204K | – | 3983 |
|
|
2017
Q2 | $204K | Buy |
+19,493
| New | +$204K | ﹤0.01% | 3156 |
|